FDA Investigator: Tina M. Pawlowski
- Tina M. Pawlowski first started conducting FDA inspections in 2004, with the last inspection in 2018. Over that time, Tina M. Pawlowski has conducted 16 inspections at 16 companies across 16 sites.
Get Tina Pawlowski's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 F. Hoffmann - La Roche Ltd., Kaiseraugst | 2009
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Eli Lilly And Company, Indianapolis | 2008
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Heraeus Precious Metals GmbH & Co., Hanau | 2007
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Apotex Inc., Etobicoke | 2006
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Caraco Pharmaceutical Laboratories, LTD., Detroit | 2005
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Ash Stevens, Inc., Riverview | 2004
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
FDA 483 Impact Analytical, Midland | 2004
Out-of-stock
Tina M. Pawlowski
Human Drug Form 483
Co-Investigators (11)
- Emilie Kahn, FDA Investigator
- Emily J. Orban, FDA Investigator
- Torrance J. Slayton, FDA Investigator
- James L. Dunnie, FDA Investigator
- Rebecca E. Dombrowski, FDA Investigator
- Ernest Bizjak, FDA Investigator
- Patsy J. Domingo, FDA Investigator
- Joey V. Quitania, FDA Investigator
- James P. McReavey, FDA Investigator
- Azza Talaat, FDA Investigator
- Art O. Czabaniuk, FDA Investigator